Description
In honour of Primary Biliary Cholangitis (PBC) awareness month, this EASL studio discusses the future therapy-landscape for patients by highlighting:
- The importance of correctly diagnosing PBC
- The need of addressing both symptoms and liver disease severity
- Current and future approaches for treating PBC
Faculty
- Prof. Gideon Hirschfield (Moderator)
- Prof. Ana Lleo (Faculty)
- Dr Femi Adekunle (Faculty, Advanz Pharma representative)
- Dr Stuart Kendrick (Faculty, GSK representative)
- Dr Charles A. McWherter (Faculty, CymaBay representative)
- Dr Claudia Zein (Faculty, Ipsen representative)
This EASL Studio is supported by Advanz Pharma, CymaBay, GSK and Ipsen.